Sign in

CIK 0001714899 · Large accelerated filer

Denali Therapeutics Inc.

Sign in to watch
Ticker
DNLI
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
463872213
Phone
(650) 866-8547
Business address
161 OYSTER POINT BLVD., SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$363,678
in 3 filings, $327K under 10b5-1 plans

Net −$363,678. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Thornberry Nancy −$262K Director sold 37% of stake
  2. Schuth Alexander O. −$65K COFO and Secretary sold <1% of stake
  3. Chin Peter Scott −$37K Chief Medical Officer sold <1% of stake
Date Insider Transaction Shares Price Value Owned after
2021-02-11 Ho Carole Chief Medical Officer Sale −400 $71.49 $29K 172,233
2021-02-11 Schuth Alexander O. COO and Secretary Sale −2,614 $70.17 $183K 542,015
2021-02-11 Schuth Alexander O. COO and Secretary Sale −433 $71.41 $31K 541,582
2021-02-11 Krognes Steve E. CFO and Treasurer Sale −2,635 $70.17 $185K 97,987
2021-02-11 Krognes Steve E. CFO and Treasurer Sale −400 $71.43 $29K 97,587
2021-02-11 Watts Ryan J. President and CEO Sale −8,513 $70.17 $597K 2,325,036
2021-02-11 Watts Ryan J. President and CEO Sale −960 $71.47 $69K 2,324,076
2021-02-09 Schuth Alexander O. COO and Secretary Sale −1,262 $74.66 $94K 537,550
2021-02-09 Schuth Alexander O. COO and Secretary Sale −206 $75.68 $16K 537,344
2021-02-09 Krognes Steve E. CFO and Treasurer Sale −1,022 $74.38 $76K 13,405
2021-02-09 Krognes Steve E. CFO and Treasurer Sale −426 $75.39 $32K 12,979
2021-02-09 Ho Carole Chief Medical Officer Sale −1,006 $74.40 $75K 168,385
2021-02-09 Ho Carole Chief Medical Officer Sale −364 $75.10 $27K 168,021
2021-02-09 Ho Carole Chief Medical Officer Sale −100 $76.00 $8K 167,921
2021-02-09 Watts Ryan J. President and CEO Sale −2,667 $73.24 $195K 2,316,298
2021-02-09 Watts Ryan J. President and CEO Sale −1,634 $74.05 $121K 2,314,664
2021-02-09 Watts Ryan J. President and CEO Sale −811 $75.07 $61K 2,313,853
2021-02-08 Watts Ryan J. President and CEO Option exercise +5,516 2,310,165
2021-02-08 Watts Ryan J. President and CEO Option exercise +8,800 2,318,965
2021-02-08 Watts Ryan J. President and CEO Option exercise · Restricted Stock Units −5,516 0

Page 27 of 53 · 1,053 trades